Cancer Research SABCS  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 45, 1146-1151, March 1, 1985]
© 1985 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cupo, D. Y.
Right arrow Articles by Wetterhahn, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cupo, D. Y.
Right arrow Articles by Wetterhahn, K. E.

Binding of Chromium to Chromatin and DNA from Liver and Kidney of Rats Treated with Sodium Dichromate and Chromium(III) Chloride in Vivo1

Doreen Y. Cupo and Karen E. Wetterhahn2

Department of Chemistry, Dartmouth College [K. E. W.], and Department of Biochemistry, Dartmouth Medical School [D. Y. C.], Hanover, New Hampshire 03755

The in vivo binding of chromium to whole chromatin, polynucleosomes, DNA, and cytoplasmic RNA-protein fraction from liver and kidney was examined after treatment of rats with sodium dichromate and chromium(III) chloride. Significant amounts of chromium were bound to DNA and the nonhistone proteins of chromatin and to cytoplasmic RNA-protein fraction. The binding of chromium to the nuclear and cytoplasmic nucleic acid fractions varied considerably, depending on the tissue and the oxidation state of the chromium administered. The level of chromium bound to whole chromatin was greater in the liver than in the kidney after treatment with either chromium compound. Chromium entered the liver and kidney tissues at a slower rate after chromium(III) treatment than after chromium(VI) treatment. At early times after chromium(VI) treatment, more chromium was bound to the liver and kidney chromatin and DNA than after chromium(III) treatment. A much smaller proportion of the chromium bound to chromatin was associated with the DNA after treatment with chromium(III) than after treatment with chromium(VI). However, 40 hr after injection, there was no significant difference in the level of chromium on the DNA from both the liver and kidney of chromium(VI)- and chromium(III)-treated animals. No DNA damage was detected in either liver or kidney nuclei after chromium(III) treatment, using the technique of alkaline elution. A possible correlation between chromium binding to chromatin and DNA damage is discussed.

1 This investigation was supported by Grant BC-320 from the American Cancer Society, by USPHS Grant CA34869 awarded by the National Cancer Institute, Department of Health and Human Services, by the donors of the Petroleum Research Fund, administered by the American Chemical Society, and by A. P. Sloan Research Fellowship.

2 To whom requests for reprints should be addressed.

Received 8/ 6/84. Accepted 11/ 6/84.




This article has been cited by other articles:


Home page
Cancer Res.Home page
Z. Kirpnick-Sobol, R. Reliene, and R. H. Schiestl
Carcinogenic Cr(VI) and the Nutritional Supplement Cr(III) Induce DNA Deletions in Yeast and Mice.
Cancer Res., April 1, 2006; 66(7): 3480 - 3484.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. J. Lee, N. J. Hodges, and J. K. Chipman
Interindividual Variability in Response to Sodium Dichromate-Induced Oxidative DNA Damage: Role of the Ser326Cys Polymorphism in the DNA-Repair Protein of 8-Oxo-7,8-Dihydro-2'-Deoxyguanosine DNA Glycosylase 1
Cancer Epidemiol. Biomarkers Prev., February 1, 2005; 14(2): 497 - 505.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
N.J. Hodges and J.K. Chipman
Down-regulation of the DNA-repair endonuclease 8-oxo-guanine DNA glycosylase 1 (hOGG1) by sodium dichromate in cultured human A549 lung carcinoma cells
Carcinogenesis, January 1, 2002; 23(1): 55 - 60.
[Abstract] [Full Text] [PDF]


Home page
MutagenesisHome page
N.J. Hodges, B. Adam, A.J. Lee, H.J. Cross, and J.K. Chipman
Induction of DNA-strand breaks in human peripheral blood lymphocytes and A549 lung cells by sodium dichromate: association with 8-oxo-2-deoxyguanosine formation and inter-individual variability
Mutagenesis, November 1, 2001; 16(6): 467 - 474.
[Abstract] [Full Text] [PDF]


Home page
Arch Fam MedHome page
D. J. Porter, L. W. Raymond, and G. D. Anastasio
Chromium: Friend or Foe?
Arch Fam Med, September 1, 1999; 8(5): 386 - 390.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
D. H. Phillips
Toxicology elsewhere
Human and Experimental Toxicology, July 1, 1996; 15(7): 600 - 604.
[PDF]


Home page
Hum Exp ToxicolHome page
M. Gao, S.P. Binks, J.K. Chipman, L.S. Levy, R.A. Braithwaite, and S.S. Brown
Induction of DNA Strand Breaks in Peripheral Lymphocytes by Soluble Chromium Compounds
Human and Experimental Toxicology, January 1, 1992; 11(2): 77 - 82.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1985 by the American Association for Cancer Research.